Background
Imogen works across the HIV and viral hepatitis research programs. She has a diverse background in program management and research with experience across public health, international health and biomedical research.
Since the completion of a PhD in cancer biology, Imogen has focused on international and public health, working in a range of settings including in Nepal, PNG and Indigenous Australian communities. She’s interested in innovative solutions that facilitate access and provision of health care services for vulnerable communities, and in improving health outcomes and equity through health system strengthening.
View all publications.
Positions
- 2019 - present: Research Program Manager, Burnet Institute
- 2018 - 2019: Program Manager, Victorian Comprehensive Cancer Centre
- 2016 - 2018: Research Fellow, University of Melbourne
- 2014 - 2016: International Clinical Research Fellow, Burnet Institute
- 2013 - 2014: Research and Evaluation Officer, Australia Youth Ambassador for Development, Nepal Network of Cancer Treatment and Research, Nepal
- 2011 - 2013: Postdoctoral Researcher, Peter MacCallum Cancer Centre
Qualifications
- 2018: MPH, Monash University
- 2011: PhD, University of Melbourne
- 2006: BSc (Hons) University of Melbourne
- 2005: BMedSc, Australian National University
Projects (3)
Current (3)
Publications (15)
2022 (1)
- Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
BMJ Open. 2022 Jan; 12(1):e057618
2021 (2)
- A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign.
Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, Stoove M, Doyle JS, Pedrana A, Scott N; EC Partnership
J Viral Hepat. 2021 Aug; 28(11):1624-1634
- Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.
Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A; Eliminate Hepatitis C Partnership
J Viral Hepat. 2021 Jan; 28(3):569-572
2020 (1)
2019 (1)
2017 (2)
- High levels of transmitted HIV drug resistance in a study in Papua New Guinea.
Lavu E, Kave E, Mosoro E, Markby J, Aleksic E, Gare J, Elsum IA, Nano G, Kaima P, Dala N, Gurung A, Bertagnolio S, Crowe SM, Myatt M, Hearps AC, Jordan MR
PLoS One. 2017 Feb; 12(2):e0170265
- The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation.
Christina B Wolwer, Nathan Godde, Luke B Pase, Imogen A Elsum, Krystle Y B Lim, Faruk Sacirbegovic, Carl R Walkley, Sarah Ellis, Shigeo Ohno, Fumio Matsuzaki, Sarah M Russell, Patrick O Humbert
PLoS One. 2017 Jan; 12(1):e0170295
2014 (1)
2013 (2)
2012 (1)
2011 (1)
- SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.
Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D, Elsum I, Greenfield A, Tuveson DA, Simon R, Humbert PO
J Clin Invest. 2011 Nov; 121(11):4257-4267
2010 (1)
2008 (2)
- Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module.
Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE
Oncogene. 2008 Nov; 27(55):6888-6907
- Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling.
Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO
Oncogene. 2008 Oct; 27(46):5988-6001